Part-time jobs in South Korea

Sciwind Biosciences Reports Positive Interim Results from Phase 1c/2a Clinical Trial of XW003 (Ecnoglutide) in Overweight and Obese Adult Volunteers in China

Retrieved on: 
Tuesday, August 9, 2022
Clinical trial, Overweight, Adult, SAN, Body mass index, Part, Type 2 diabetes, Lists of diseases, Obesity, Volunteering, Part-time jobs in South Korea, BMI, Wine, Pharmaceutical industry

XW003 is a novel, long-lasting glucagon-like peptide-1 (GLP-1) analogue that is being developed for the treatment of type 2 diabetes and obesity.

Key Points: 
  • XW003 is a novel, long-lasting glucagon-like peptide-1 (GLP-1) analogue that is being developed for the treatment of type 2 diabetes and obesity.
  • The Phase 1c/2a trial, which is being conducted in China, includes non-diabetic overweight or obese adult subjects.
  • The interim analysis was conducted after all participants completed the core treatment phase (Part A).
  • Sixty subjects participated in the trial and were randomized to receive either 1.8 mg or 2.4 mg of XW003 or placebo once weekly as subcutaneous injections.

FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease

Retrieved on: 
Friday, February 4, 2022
NASDAQ, Private Securities Litigation Reform Act, Part, Forward-looking statement, Cold agglutinin disease, Intellectual property, Regulation, Medicine, Blood transfusion, Part-time jobs in South Korea, Science, Solution, Indigestion, Research, Acquisition, Annual report, Immune system, SNY, Rupture, Marketing, ULN, Cough, Human, Sutimlimab, Respiratory tract infection, Complement component 1s, Chest pain, SAN, FDA, Patient, AMF, Form 20-F, Safety, Peripheral edema, Anemia, Oxygen, SEC, Autoimmune hemolytic anemia, Degenerative disease, Streptococcus, Hemolysis, Bilirubin, SE, History, CAD, Georgetown Lombardi Comprehensive Cancer Center, Social responsibility, Diarrhea, Weakness, Insurance, Arthritis, Fatigue, Antibody, Arthralgia, COVID-19, Vaccine, Pharmaceutical industry, Health insurance, Sanofi

Enjaymo is the only approved treatment to inhibit red blood cell destruction in CAD and help stop the chain reaction from the start.

Key Points: 
  • Enjaymo is the only approved treatment to inhibit red blood cell destruction in CAD and help stop the chain reaction from the start.
  • For the first time, we have a treatment that targets complement-mediated hemolysis, which is the underlying cause of the red blood cell destruction in many CAD patients.
  • Dosage interruptions due to an adverse reaction occurred in 17 percent (4/24) of patients who received Enjaymo.
  • Following the completion of the 26-week treatment period of CARDINAL (Part A), eligible patients continued to receive Enjaymo in an extension study.

Fast-growing Restaurant Chain Maple Street Biscuits Implements Landed App to Accelerate Hiring in Challenging Labor Market

Retrieved on: 
Wednesday, January 26, 2022
People, Maple Street Historic District (Southbridge, Massachusetts), Restaurant, Part-time jobs in South Korea, ASAP, General manager, SAN, Brand, Environment, Goal, Community, Blaze Pizza, AI, Interview, GLOBE, Â, Employment agency, Chick-fil-A, Landed, Panera Bread

For new store openings, these positions are hired within a month, in an extremely challenging hiring environment.

Key Points: 
  • For new store openings, these positions are hired within a month, in an extremely challenging hiring environment.
  • Since implementing Landed in Oct 2021, Maple Street has achieved that goal for each new store opening, fully staffing each store.
  • Landed has also helped Maple Street double its staff levels at its existing locations and grow application flow in challenging markets by 7.5x.
  • Hiring managers download the Landed Employer mobile app, and input hiring goals such as role titles, headcount, pay rate and locations.

Advanced Time & Jobs Tracking Drives allGeo Adoption with Operations and Payroll Teams

Retrieved on: 
Thursday, October 21, 2021
Timesheet, CA, PALO, Controller, QR, Workflow, Mileage, Adoption, Time clock, Electronic visit verification, Part-time jobs in South Korea, Time, ADP, CEO, Silicon, Awareness, QuickBooks, Automation, Pay, Technique for human error-rate prediction, Online shopping

allGeo has partnered with several major payroll providers in order to offer its advanced time & jobs tracking capabilities to payroll teams.

Key Points: 
  • allGeo has partnered with several major payroll providers in order to offer its advanced time & jobs tracking capabilities to payroll teams.
  • In a short period of time, allGeo has successfully worked with numerous customers needing Time & Jobs tracking and comprehensive payroll integration capabilities.
  • Payroll teams have a strong need to get time tracking data integrated with their payroll system.
  • Through the "time tracking to payroll" workflow, allGeo can perform highly accurate time tracking, apply custom pay rate logic, and seamlessly integrate all the time tracking data with the customers payroll system.